Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT(3) antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin - Analysis of combined data from two Phase III randomized clinical trials

RJ Gralla, Ronald de Wit, J Herrstedt, AD Carides, J Ianus, J Guoguang-Ma, JK Evans, KJ Horgan

Research output: Contribution to journalArticleAcademicpeer-review

87 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)864-868
Number of pages5
JournalCancer
Volume104
Issue number4
DOIs
Publication statusPublished - 2005

Cite this